FRA Grants Quest Diagnostics (DGX) First Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in MS Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. FMG:AU

Go back to FRA Grants Quest Diagnostics (DGX) First Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in MS Patients
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 218.06 +3.71 (1.73%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.92 
Day Low $215.00    EPS $7.81 
Volume 248,765       

Quest Diagnostics (NYSE: DGX) Delayed: 244.09 +2.79 (1.16%)
Previous Close $241.30    52 Week High $86.85 
Open $240.33    52 Week Low $59.66 
Day High $244.34    P/E 45.97 
Day Low $239.43    EPS $5.31 
Volume 318,691       

Elan Corp. PLC ADS (NYSE: ELN) Delayed: 18.12 --0 (-0%)
Previous Close $18.12    52 Week High $18.21 
Open $18.12    52 Week Low $9.37 
Day High $18.12    P/E N/A 
Day Low $18.12    EPS $0.00 
Volume 100